Skip to content
Disclosery

CAXTON ASSOCIATES LLP: BIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CAXTON ASSOCIATES LLP on BIO, newest first. How the timeline and the estimate are built.

CAXTON ASSOCIATES LLP held 13,875 BIO shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 13,875 shares
    Change vs previous 13F +13,875 shares

    0.08% of the 13F portfolio, value $4,073,839.

    13F-HR 0002051323-26-000013 filed by CAXTON ASSOCIATES LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -1,467 shares

    13F-HR 0002051323-26-000009 filed by CAXTON ASSOCIATES LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  3. period ended2025-12-31
    13F 1,467 shares
    Change vs previous 13F +1,467 shares

    0.01% of the 13F portfolio, value $444,486.

    13F-HR 0002051323-26-000006 filed by CAXTON ASSOCIATES LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -2,998 shares

    13F-HR 0002051323-25-000011 filed by CAXTON ASSOCIATES LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2025-03-31
    13F 2,998 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $730,193.

    13F-HR 0002051323-25-000006 filed by CAXTON ASSOCIATES LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).